Chapter 10. Medicine and the Media: Good Information or Misleading Hype?

  1. Nick Freemantle1 and
  2. Suzanne Hill2
  1. Moynihan Ray,
  2. Lisa M Schwartz and
  3. Steven Woloshin

Published Online: 5 NOV 2007

DOI: 10.1002/9780470994719.ch10

Evaluating Pharmaceuticals for Health Policy and Reimbursement

Evaluating Pharmaceuticals for Health Policy and Reimbursement

How to Cite

Ray, M., Schwartz, L. M. and Woloshin, S. (2007) Medicine and the Media: Good Information or Misleading Hype?, in Evaluating Pharmaceuticals for Health Policy and Reimbursement (eds N. Freemantle and S. Hill), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470994719.ch10

Editor Information

  1. 1

    Department of Primary Care and General Practice, University of Birmingham,Birmingham,UK

  2. 2

    Faculty of Health,University of Newcastle,Newcastle, Australia

Publication History

  1. Published Online: 5 NOV 2007
  2. Published Print: 1 AUG 2004

ISBN Information

Print ISBN: 9780727917843

Online ISBN: 9780470994719

SEARCH

Keywords:

  • mass media;
  • celebrex;
  • medical technologies;
  • health care;
  • pharmaceutical industry

Summary

This chapter contains sections titled:

  • Introduction

  • Cheer squad or watchdog?

  • Media coverage of medicine and health care influences the general public and physicians

  • How well do medical news stories cover medicine?

  • Benefits

  • Harms

  • Balance of benefits and harms

  • Costs

  • Conflicts of interest

  • Can media coverage of medicine be improved?

  • When scepticism should be high

  • Medicalisation of ordinary experience

  • Preliminary research findings: meetings

  • Cost-effectiveness before effectiveness

  • Conclusion

  • References